|
Protected Antimicrobial |
Approved use |
|
Aciclovir (IV) |
|
|
Anidulafungin |
Microbiologist or Infectious Disease Consultant approval required |
|
Aztreonam |
Microbiologist or Infectious Disease Consultant approval required |
|
Caspofungin |
Patient under the care of a Consultant Haematologist or Consultant in Critical Care |
|
Cefotaxime |
Patient under the care of a Consultant Paediatrician |
|
Ceftazidime
|
1) Patient has a proven/suspected pseudomonal chest infection, has failed to respond to alternative antipseudomonal agents and is under the care of a Consultant in Respiratory Medicine. 2) Patient under the care of a Consultant Paediatrician |
|
Ceftriaxone |
(further doses require Microbiologist approval) |
|
Cefuroxime |
1) Only as per orthopaedic surgery prophylaxis guidelines for a maximum duration of 24 hours 2) Empirical treatment of sepsis in obstetric patients |
|
Daptomycin |
Patient under the care of OPAT |
|
Ertapenem |
1) Microbiologist or Infectious Disease Consultant approval required 2) Patient under the care of OPAT |
|
Fidaxomicin |
Microbiologist or Infectious Disease Consultant approval required |
|
Fosfomycin IV (oral fosfomycin does not require a code) |
Microbiologist or Infectious Disease Consultant approval required |
|
Linezolid |
1) Patient under the care of a Consultant in Critical Care 2) Patient with MRSA infection under the care of a Vascular Surgeon |
|
Meropenem
|
1) Patient under the care of a Consultant Haematologist or a Consultant in Critical Care 2) 1st dose for suspected necrotising fasciitis; further doses require Microbiologist approval 3) 1st dose for suspected neutropenic sepsis; further doses require Microbiologist approval |
|
Piperacillin-Tazobactam
|
1) Neutropenic sepsis 2) Patient under the care of a Consultant in Critical Care 3) Cystic fibrosis or bronchiectasis (when advised by a Consultant in Respiratory Medicine or Paediatrics) |
|
Posaconazole |
Patient under the care of a Consultant Haematologist |
|
Rifaximin
|
Patient under the care of a GI Consultant and only for the prevention of hepatic encephalopathy (2nd line agent) |
|
Teicoplanin |
1) Patient under the care of OPAT or Hospital at Home 2) Surgical prophylaxis, single dose as per individual protocol 3) Neutropenic sepsis |
|
Tigecycline |
Microbiologist or Infectious Disease Consultant approval required |
|
Voriconazole |
1) Patient under the care of a Consultant in Respiratory Medicine or a Consultant Haematologist 2) Patient under the care of a Renal Consultant only for fungal PD peritonitis |